First National Bank of Omaha Acquires New Shares in Colgate-Palmolive Company $CL

First National Bank of Omaha bought a new stake in Colgate-Palmolive Company (NYSE:CL) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,856 shares of the company’s stock, valued at approximately $468,000.

Several other institutional investors also recently modified their holdings of CL. Tiemann Investment Advisors LLC grew its holdings in Colgate-Palmolive by 2.1% during the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after purchasing an additional 125 shares during the period. Westside Investment Management Inc. increased its holdings in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after acquiring an additional 130 shares in the last quarter. S.A. Mason LLC raised its position in shares of Colgate-Palmolive by 3.9% during the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock worth $280,000 after purchasing an additional 130 shares during the period. Security National Bank of Sioux City Iowa IA grew its position in shares of Colgate-Palmolive by 0.8% in the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock valued at $1,298,000 after purchasing an additional 130 shares during the period. Finally, Stratos Wealth Advisors LLC increased its stake in Colgate-Palmolive by 4.5% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after purchasing an additional 130 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CL has been the subject of several research analyst reports. Bank of America upped their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, February 2nd. JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Evercore lifted their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, February 2nd. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a report on Tuesday, December 9th. Finally, TD Cowen restated a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $94.38.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the sale, the insider owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 184,683 shares of company stock worth $17,486,693. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $93.93 on Friday. The firm has a market capitalization of $75.71 billion, a P/E ratio of 35.85, a price-to-earnings-growth ratio of 4.31 and a beta of 0.29. The company has a current ratio of 0.42, a quick ratio of 0.27 and a debt-to-equity ratio of 5.90. The firm’s fifty day moving average price is $85.28 and its two-hundred day moving average price is $82.19. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 EPS. As a group, research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.